Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2022-07-28 00:00:00 ET · period of report 2022-07-26 · accession 0001104659-22-083680 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-28 | 2022-07-27 | RYTM | Cramer Pamela J. | CHRO | S - Sale+OE | $11.68 | -901 | 2,224 | -29% | -$10.5K |
| D | 2022-07-28 | 2022-07-26 | RYTM | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 3,125 | New | — |
| D | 2022-07-28 | 2022-07-26 | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $0.00 | +3,125 | 9,375 | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-27 | S | D | 901 | $11.68 | 2,224 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-26 | M | A | 3,125 | — | 3,125 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2022-07-26 | M | A | 3,125 | $0.00 | 9,375 | D | — · — to — | 3,125 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date. |